×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Bridging Randomized Clinical Trials and Real-World Data Utilizing Data Linkage and Tokenization
Session Chair(s)
Aaron Kamauu, MD, MPH, MS
CEO
Navidence LLC, United States
Data linkage is a methodology to capture data from patients before, during, and after a clinical trial. The panel will discuss the challenges of conducting randomized clinical trials (RCTs) linked with real-world data (RWD), and will emphasize the data linkage methodologies and current needs.
Learning Objective : Describe the methodology of data linkage, a relatively new method to collect individual patient data before, during, and after a clinical trial outside the randomized clinical trial (RCT) setting; Discuss challenges for different stakeholders involved in utilization of real-world evidence (RWE) and more specifically data linkage, including industry, regulators, and payers/HTA.
Speaker(s)
Panelist
Francesco Pignatti, MD
European Medicines Agency, Netherlands
Scientific Adviser for Oncology
Panelist
Kajsa Kvist
Novo Nordisk, Denmark
Scientific Vice President
Panelist
Brian Bradbury, DrSc, MA
Amgen, United States
Vice President, Center for Observational Research
Panelist
Akshay Vashist
Otsuka Pharmaceutical Development & Commercialization, United States
Exec Dir Head Medical Real World Data Analytics
Have an account?